SC99
SC99 is a selective small molecule inhibitor that targets the JAK2-STAT3 signaling pathway, suppressing the expression of downstream genes. It demonstrates potent antiplatelet and antithrombotic activity, and has shown efficacy in preclinical models of multiple myeloma, supporting its use in hematological and cardiovascular research.
Product Specifications
CAS Number
882290-02-0
Product Name Alternative
ERK, Inhibitor, inhibit, myeloma, multiple, JAK, Janus kinase, JAK2, mTOR, orally, OPM2, c-Src, Apoptosis, ATP-binding, anti-myeloma, anti-thrombotic, activation, aggregation, AKT, pocket, phosphorylation, platelet, STAT, STAT3, SC 99, SC99, SC-99
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Purity
99.56% (May vary between batches)
Solubility
DMSO:82 mg/mL (243.94 mM)
Smiles
Fc1ccc (N\N=C (/C#N) C (=O) c2ccc (Cl) cc2) cc1Cl
Molecular Formula
C15H8Cl2FN3O
Molecular Weight
336.15
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
